Search for: "Provider Technologies, Inc." Results 41 - 60 of 10,537
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
  However, the current generative AI licensing market provides a helpful precedent as to why this likely will not happen in the technology’s early days. [read post]
” As AI slowly and surely becomes a part of work life, both leaders and employees need to ensure that their use of the technology is ethical, responsible, and explainable. [read post]
7 May 2024, 6:12 am by admin
 See, NLRB Advice Memorandum Dated April 16, 2019, Uber Technologies, Inc. [read post]
4 May 2024, 8:31 pm by Cynthia Marcotte Stamer
Solutions Law Press, Inc. invites you to receive future updates by registering on  here and participating and contributing to the discussions in our Solutions Law Press, Inc. [read post]
3 May 2024, 9:02 am by Dennis Crouch
Chalk & Vermilion Fine Arts, Inc., 514 F.3d 1063 (10th Cir. 2008) and Bancroft & Masters, Inc. v. [read post]
30 Apr 2024, 5:42 am by David Kessler (US) and Susan Ross (US)
  In December 2020, the company revised its privacy policy (increasing its size to 15 pages) and added a statement that it used Facebook Pixel, a web analytics and advertising service by Facebook, Inc. that “uses cookies, pixel tags, and other storage and tracking technology to collect or receive information from [Cerebral’s] [w]ebsites and [a]pps based on [consumers’] usage activity. [read post]
30 Apr 2024, 4:00 am by Sean Bruns
It is intended to provide guidance and insight for market participants, regulators and technology providers regarding the potential use of generative artificial intelligence (genAI) in the over-the-counter (OTC) derivatives market. [read post]
30 Apr 2024, 4:00 am by Sean Bruns
It is intended to provide guidance and insight for market participants, regulators and technology providers regarding the potential use of generative artificial intelligence (genAI) in the over-the-counter (OTC) derivatives market. [read post]
30 Apr 2024, 4:00 am by Sean Bruns
It is intended to provide guidance and insight for market participants, regulators and technology providers regarding the potential use of generative artificial intelligence (genAI) in the over-the-counter (OTC) derivatives market. [read post]